Gene Therapy CMC & Manufacturing Approaches Are Maturing
By Tonia Becker, Life Sciences Editor, Macon Raine The gene therapy sector is maturing and the industry is poised to be able to produce products in more consistent and scalable ways. Although the COVID-19 pandemic caused some delays, on the whole, projects are moving...
New European Medical Device Regulations Delayed Due to COVID-19 Pandemic
Tonia Becker, Life Sciences Editor, Macon Raine talks with BioTechLogic’s Ted Condez How is the medical device and biopharmaceutical market faring during the COVID-19 pandemic? For an answer to this question, there is no better place to turn to than...
Lessons from and Insights into the Korean Biopharmaceutical Market During the COVID-19 Pandemic
Tonia Becker, Life Sciences Editor, Macon Raine talks with BioTechLogic’s Dr. Eileen Choi How is the COVID-19 pandemic affecting the global biopharmaceutical market? To get at least some perspective on this question, there is no better place to turn to than...
Biopharmaceutical Developers Tackle COVID-19 Pandemic-Inflicted Challenges
Tonia Becker, Life Sciences Editor, Macon Raine, talks with BioTechLogic’s Dr. Mike Berry. Knowing that BioTechLogic’s team of biopharmaceutical consultants is working with many companies in the industry to help speed the path to market, I was interested in...
Contact Surface and Hand Disinfection – Applying Pharma’s Disinfectant Efficacy Concepts for COVID-19
By Tracy TreDenick-Fricke, BioTechLogic, Head of Regulatory and Quality, and Senior Consultant Most of us now understand that SARS-CoV-2 (the cause of COVID-19) is often transmitted via respiratory droplets. However, SARS-CoV-2 is also spread by contaminated contact surfaces and hands, but all contact surfaces are not created equally. A chart published by the Journal of Hospital Infection is quite helpful for understanding the persistence of the virus on various surfaces.